comprehensive -WSS

comprehensive

author：explore 2025-10-01 12:34:06 - browse：855

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons.

The medicine, marketed as Lenmeldy, is the first treatment for MLD, which is otherwise fatal. Lenmeldy has to be given before symptoms appear or, in some cases, after the first signs of disease, so it won’t be helpful for many patients living with MLD today. But when given in time, it appears to be near-curative, allowing some children to grow up and attend school with unaffected peers.

Lenmeldy is already marketed in Europe, under the name Libmeldy, and has helped a handful of patients in the U.S. who were treated under compassionate use, as their doctors feared they didn’t have time to wait for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Emergent cuts jobs, executive role in business shake

WSS

Methadone doses haven’t kept up in the age of fentanyl

Maui's cultural, historic landmarks damaged in the devastating wildfires

R1 RCM gets $5.8 billion buyout offer from private equity firm

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Maui's cultural, historic landmarks damaged in the devastating wildfires

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

hotspot

comprehensive

focus

In Memoriam: Notable people who died in 2023

In utero gene editing: an explainer

Cancer drug shortages should be causing more outrage

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Trump demands the U.S. pay no more for drugs than other countries … again

R1 RCM gets $5.8 billion buyout offer from private equity firm

State Dept. review finds Biden bears some blame for Afghanistan failures

Antivenom research: Lessons from HIV applied in search for universal antidote

Activists slam private health insurers over coverage restrictions

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

focus

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Alabama hospital puts IVF treatments on hold

American woman, child freed after being kidnapped in Haiti last month

Why failed clinical trials don’t always spell doom for a new drug

NIH trials fail to test meaningful long Covid therapies, experts say

Wegovy’s successful heart trial raises vital question about weight loss

hotspot

focus

focus

hotspot